OXYCHEM Market Analysis and Guidance
FINANCIALS
SECOND QUARTER 2023 RESULTS
Reported Production versus
Guidance Midpoint Reconciliation
13
Mboed
Reported
Adjusted diluted EPS1
ROCKIES
$0.68
Reported diluted EPS1
$0.63
Strong base and new well performance,
higher OBO volumes, nonrecurring royalty
receipt
+28
PERMIAN
CFFO before working capital
$2.7 B
Strong base and new well performance in the
Delaware, interest adjustments
+14
Capital expenditures
$1.6 B
GULF OF MEXICO
+6
Unrestricted cash balance as of 06/30/2023
$0.5 B
Higher base performance
INTERNATIONAL
Continuing operations production (Mboed)
1,218
PSC driven impacts
(6)
OxyChem EBIT
$436 MM
+42
Midstream Adjusted EBIT
$(78) MM
NOTE: SEE THE RECONCILIATIONS TO COMPARABLE GAAP FINANCIAL MEASURES ON OUR WEBSITE;
CASH FLOW FROM OPERATIONS (CFFO); OPERATED BY OTHERS (OBO); PRODUCTION SHARING CONTRACT (PSC)
1ADJUSTED AND REPORTED DILUTED SHARE COUNT 958.8 MM SHARES
OXYView entire presentation